intranasal glutathione Nasal Spray - Immunity & Detox Effect of intranasal administration of

2000 May;157(5):715-21

Acta 1592 , 213214 (2002)

The synergistic combination is studied for its potential to support cell migration, tissue healing and reduce inflammatory processes

Comparison with Similar Peptides GHK-Cu (Current) Half-Life:~2 hours Dosage:1-2 mg daily Administration:Topical or subcutaneous Research Status: Preclinical/Experimental Half-Life:~4 hours Dosage:200-500 mcg daily Administration:Subcutaneous injection Research Status: Preclinical/Experimental Half-Life:~2-3 days Dosage:2-5 mg per week Administration:Subcutaneous injection Research Status: Preclinical/Experimental Half-Life:~2-3 hours Dosage:2-4 IU daily Administration:Subcutaneous injection Research Status: FDA Approved (for specific conditions) Half-Life:~24 hours Dosage:10-25 mg daily Administration:Oral Research Status: Experimental Half-Life:~12 minutes Dosage:1-2 mg daily Administration:Subcutaneous injection Research Status: FDA Approved (for specific conditions) Highlighted rowcard shows the current peptide

Milk thistle provides complementary liver support, making this a genuinely synergistic formula rather than a standalone single-ingredient product